Related Experiment Video
Updated: Aug 28, 2025
09:32
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
7.2K
Reducing costs in atopic dermatitis
Elisha M Myers1, Patrick O Perche1, Joseph L Jorizzo1
1Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Dermatologic Therapy
|September 22, 2022
Summary
Managing atopic dermatitis (AD) involves cost-effective strategies like prophylactic moisturizers and patient education. Tailoring treatments by severity, including corticosteroids for mild cases and considering phototherapy for severe AD, reduces overall healthcare costs.
Area of Science:
- Dermatology
- Health Economics
Background:
- Atopic dermatitis (AD) is a prevalent, chronic inflammatory skin condition with significant direct and indirect costs.
- AD disproportionately affects children and minority populations, with high treatment costs posing barriers to care.
Purpose of the Study:
- To review and describe cost-conscious treatment and management strategies for atopic dermatitis.
- To identify methods for reducing the economic burden associated with AD.
Main Methods:
- A literature review was conducted using PubMed.
- Keywords included: AD, cost, medications, treatment, management, efficacy, adherence, education, and prophylactic.
Main Results:
- Prophylactic moisturizer use in high-risk infants may decrease AD incidence and costs.
- Improving medication adherence and consistent moisturizing reduce costs.
- Corticosteroids are cost-effective for mild AD; severe AD may require costly biologics or cost-effective phototherapy.
- Patient and family education programs reduce long-term management costs.
Conclusions:
- Reducing AD treatment costs requires a multifaceted approach.
- Key strategies include prophylactic therapies, patient education, and disease severity-tailored management.
- A comprehensive approach can lower costs and overcome healthcare barriers.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
412
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
412
01:17Drugs Used in Lower Respiratory Disorders: Overview
559
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
559
01:26Atherosclerosis III: Management
25
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
25
01:19Antiasthma Drugs: Leukotriene Modifiers
421
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
421
01:26COPD: Management Using Bronchodilators and Corticosteroids
282
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
282
01:22Methods of reducing fever
732
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
732